Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-17466House Oversight

Biopharma Fund Investment Strategy Document

Other

The passage is a generic investment prospectus describing target company profiles and past exits. It contains no specific allegations, financial flows, or connections to high‑profile individuals or ag Describes two investment profiles: clinical‑stage product programs and novel platforms. Lists example companies (Array Biopharma, Chimerix, Versartis, Pearl Therapeutics, Epizyme, Principi Mentions t

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024043
Pages
1
Persons
2
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.